High-dose magnesium sulfate infusion protocol for status asthmaticus: a safety and pharmacokinetics cohort study
Tóm tắt
To assess the safety and pharmacokinetics of high-dose magnesium sulfate (MgSO4) infusion in pediatric patients with status asthmaticus. A prospective cohort study within a 20-bed pediatric intensive care unit in an academic community hospital. Patients 2–18 years of age admitted with status asthmaticus between 10/2009 and 8/2010 were included in the study. All patients received standard therapy for asthma, while the treatment group received an intravenous magnesium sulfate bolus of 50–75 mg/kg (0.2–0.3 mmol/kg) followed by 40 mg/kg/h (0.16 mmol/kg/h) for 4 h. Patients were monitored for cardiorespiratory complications. The treatment group underwent four blood draws to assess pharmacokinetic parameters. Nineteen patients were in the treatment group and 38 patients in the control group after exclusion criteria and consenting were completed. No clinically significant differences were found between groups. There were no interventions or discontinuations of MgSO4 due to adverse events. In the treatment group, three patients had mild infusion-related reactions. Heart rate and respiratory rate were statistically significantly lower in the magnesium treatment group. The continuous infusions of MgSO4 were safe at the studied doses and maintained serum magnesium (SrMg) and ionized magnesium levels similar to levels required to produce smooth muscle relaxation in other clinical settings. Further studies are needed to investigate the efficacy of high-dose continuous MgSO4 infusion as an adjunctive treatment for severe asthma treatment and determine the SrMg level required to maintain airway smooth muscle relaxation.
Tài liệu tham khảo
Sibai BM, Graham JM, McCubbin JH (1984) A comparison of intravenous and intramuscular magnesium sulfate regimens in preeclampsia. Am J Obstet Gynecol 150:728–733
Natale JE, Guerguerian AM, Joseph JG, McCarter R, Shao C, Slomine B, Christensen J, Johnston MV, Shaffner DH (2007) Pilot study to determine the hemodynamic safety and feasibility of magnesium sulfate infusion in children with severe traumatic brain injury. Pediatr Crit Care Med 8:1–9
Raimondi F, Migliaro F, Capasso L, Ausanio G, Bisceglia M, Giliberti P, Messina F, Salvia G, Paludetto R (2008) Intravenous magnesium sulphate vs. inhaled nitric oxide for moderate, persistent pulmonary hypertension of the newborn. A multicentre, retrospective study. J Trop Pediatr 54:196–199
Ma L, Liu WG, Zhang JM, Chen G, Fan J, Sheng HS (2010) Magnesium sulphate in the management of patients with aneurysmal subarachnoid haemorrhage: a meta-analysis of prospective controlled trials. Brain Inj 24:730–735
Cheuk DK, Chau TC, Lee SL (2005) A meta-analysis on intravenous magnesium sulphate for treating acute asthma. Arch Dis Child 90:74–77
Schuh S, Macias C, Freedman SB, Plint AC, Zorc JJ, Bajaj L, Black KJ, Johnson DW, Boutis K (2010) North American practice patterns of intravenous magnesium therapy in severe acute asthma in children. Acad Emerg Med 17:1189–1196
Ciarallo L, Brousseau D, Reinert S (2000) Higher-dose intravenous magnesium therapy for children with moderate to severe acute asthma. Arch Pediatr Adolesc Med 154:979–983
Gürkan F, Haspolat K, Boşnak M, Dikici B, Derman O, Ece A (1999) Intravenous magnesium sulphate in the management of moderate to severe acute asthmatic children nonresponding to conventional therapy. Eur J Emerg Med 6:201–205
Pabon H, Monem G, Kissoon N (1994) Safety and efficacy of magnesium sulfate infusions in children with status asthmaticus. Pediatr Emerg Care 10:200–203
Irazuzta J, Wassil SK, Egelund T (2012) Feasibility and safety of short term infusion of magnesium sulfate in status asthmaticus. J Pediatr Pharmacol Ther (Accepted)
Magnesium Sulfate Injection 50 % (2007). APP Pharmaceuticals. Package insert. Dec 2007
Rosello JC, Pla HJ (1936) Sulfato de magnesio en la crisis de asma. Prensa Med Argentina 23:1677–1680
Del Castillo J, Engbaek L (1954) The nature of the neuromuscular block produced by magnesium. J Physiol 124:370–384
Gourgoulianis KI, Chatziparasidis G, Chatziefthimiou A, Molyvdas PA (2001) Magnesium as a relaxing factor of airway smooth muscles. J Aerosol Med 14:301–307
Chesley LC, Tepper I (1958) Some effects of magnesium loading upon renal excretion of magnesium and certain other electrolytes. J Clin Invest 37:1362–1372
Devi PR, Kumar L, Singhi SC, Prasad R, Singh M (1997) Intravenous magnesium sulfate in acute severe asthma not responding to conventional therapy. Indian Pediatr 34:389–397
Aali BS, Khazaeli P, Ghasemi F (2007) Ionized and total magnesium concentration in patients with severe preeclampsia-eclampsia undergoing magnesium sulfate therapy. J Obstet Gynaecol Res 33:138–143
Handwerker SM, Altura BT, Chi DS, Altura BM (1995) Serum ionized magnesium levels during intravenous MgSO4 therapy of preeclamptic women. Acta Obstet Gynecol Scand 74:517–519
Yoshida M, Matsuda Y, Akizawa Y, Ono E, Ohta H (2006) Serum ionized magnesium during magnesium sulfate administration for preterm labor and preeclampsia. Eur J Obstet Gynecol Reprod Biol 128:125–128
Yoshioka H, Hirota K, Sato T, Hashimoto Y, Ishihara H, Matsuki A (2001) Spasmolytic effect of magnesium sulfate on serotonin-induced pulmonary hypertension and bronchoconstriction in dogs. Acta Anaesthesiol Scand 45:435–440
De Nicola L, Monem G, Saldejeno V (1995) Magnesium sulfate kinetics in children. In: Poster presented at University of Florida Pediatric Science Day. Gainesville, FL
Zervas E, Papatheodorou G, Psathakis K, Panagou P, Georgatou N, Loukides S (2003) Reduced intracellular Mg concentrations in patients with acute asthma. Chest 123:113–118
Sinert R, Spektor M, Gorlin A, Doty C, Rubin A, Altura BT, Altura BM (2005) Ionized magnesium levels and the ratio of ionized calcium to magnesium in asthma patients before and after treatment with magnesium. Scand J Clin Lab Inves 65:659–670
Escuela MP, Guerra M, Añón JM, Martínez-Vizcaíno V, Zapatero MD, García-Jalón A, Celaya S (2005) Total and ionized serum magnesium in critically ill patients. Intensive Care Med 31:151–156
Glover ML, Machado C, Totapally BR (2002) Magnesium sulfate administered via continuous intravenous infusion in pediatric patients with refractory wheezing. J Crit Care 17:255–258
Beuther DA, Weiss ST, Sutherland ER (2006) Obesity and asthma. Am J Respir Crit Care Med 174:112–119
Carroll CL, Stoltz P, Raykov N, Smith SR, Zucker AR (2007) Childhood overweight increases hospital admission rates for asthma. Pediatrics 120:734–740